Gynecology

Sameena Rahman, MD, FACOG, asserts that the word "metabolic" in PMOS should fundamentally change clinical perceptions, transforming it from a GYN issue into a universally treated systemic condition.

The vaginal insert will be available starting May 19, 2026.

According to a publication in The Lancet, a multistep process was used to generate a new name to avoid misleading references to ovarian cysts while accurately reflecting the condition's diverse features.

Take a look back at our coverage (so far) of the 2026 ACOG meeting in Washington, DC

The review of over 120 studies published since 2024 found no credible evidence linking HPV vaccination to serious adverse pregnancy outcomes or other long-term health risks.

Contemporary OB/GYN will be on site in Washington, D.C. to cover the latest data out of the 75th Annual ACOG Clinical & Scientific Meeting.

Utepreva LLC has launched a proprietary, FDA-cleared endometrial sampler that combines suction, disruption, and absorption to improve tissue yield in 20-second office procedures.

Ramu Perni highlights how the "one tube" workflow streamlines obstetric practices by enabling add-on RBC and platelet antigen tests.

The incidence of SUI at 6 weeks post partum was 8.7% for the PEFLOW group compared to 13.9% for those receiving usual care (P = .03).

ACOG now recommends a combination of transvaginal ultrasonography and endometrial tissue sampling for the initial evaluation of most patients presenting with postmenopausal bleeding.

According to ACOG, approximately 90% of patients diagnosed with endometrial cancer have postmenopausal bleeding. Read more on the College's updated recommendations below.

Scott Sullivan, MD, highlights that a third of Virginia is a maternity desert, creating even more severe gaps for patients requiring maternal-fetal medicine.

The FDA cleared the Onclarity HPV Self-Collection Kit, allowing patients to collect samples at home for processing via the FDA-cleared BD Onclarity HPV Assay and BD COR System.

LiSWT may offer a noninvasive option for postpartum pelvic pain, with potential benefits across both chronic and earlier-stage scar-related dysfunction.

PinkDx announced an IJGC publication of data that demonstrated signals associated with endometrial cancer can be detected from a vaginal swab.

Simon highlights the "seamless handoff" between FQHCs and OB hospitalists as a vital mechanism for maintaining delivery access in rural and underserved communities.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

Livi is a single-use, soft polyurethane foam device cleared by the FDA to absorb semen and vaginal discharge within approximately 60 seconds.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

Among a survey of over 800 providers, menopause care was the top area for expected greatest improvement over the next 5 years.

Among 2029 women in Scandinavian countries who were followed up for 14 years, vaccine effectiveness was 100%.

A case report describes the first known use of low-intensity extracorporeal shock wave therapy for episiotomy scar pain, with a patient reporting meaningful improvement after more than 20 years of chronic pelvic floor dysfunction.

Sara Perelmuter advocates for routine postpartum screening and provider education on lactation-safe therapies when dealing with GSL symptoms.

Clinicians are advised to discuss reproductive risks and fertility preservation options with all cancer patients prior to initiating therapy to maximize future reproductive potential.